ArticleMolecular cancer therapeutics2021

Preclinical and Early Clinical Development of PTC596, a Novel Small-Molecule Tubulin-Binding Agent.

Finith Jernigan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.